Pulmuone Co Ltd
KRX:017810

Watchlist Manager
Pulmuone Co Ltd Logo
Pulmuone Co Ltd
KRX:017810
Watchlist
Price: 17 260 KRW 0.58% Market Closed
Market Cap: 658B KRW
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+69%
Revenue
Forecast
+2%
Operating Income
Forecast
N/A
Net Income
Forecast
N/A

Wall Street
Price Targets

Price Targets Summary
Pulmuone Co Ltd

Wall Street analysts forecast Pulmuone Co Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Pulmuone Co Ltd is 15 810 KRW with a low forecast of 14 140 KRW and a high forecast of 17 850 KRW.

Lowest Forecast
Wall Street Target
14 140 KRW
18% Downside
Average Forecast
Wall Street Target
15 810 KRW
8% Downside
Highest Forecast
Wall Street Target
17 850 KRW
3% Upside
Lowest
Price Target
14 140 KRW
18% Downside
Average
Price Target
15 810 KRW
8% Downside
Highest
Price Target
17 850 KRW
3% Upside
Pulmuone Co Ltd Competitors:
Price Targets
GRUMAB
Gruma SAB de CV
16% Upside
VIS
Viscofan SA
20% Upside
P
PPB
PPB Group Bhd
25% Upside
B
600597
Bright Dairy and Food Co Ltd
8% Upside
GRUMAB
Gruma SAB de CV
16% Upside
VIS
Viscofan SA
20% Upside
P
PPB
PPB Group Bhd
25% Upside
B
600597
Bright Dairy and Food Co Ltd
8% Upside
2809
Kewpie Corp
38% Upside
1475
Nissin Foods Co Ltd
6% Upside
Z
603237
Zhejiang Wufangzhai Industry Co Ltd
31% Upside
CALM
Cal-Maine Foods Inc
15% Upside

Revenue
Forecast

Revenue Estimate
Pulmuone Co Ltd

For the last 8 years the compound annual growth rate for Pulmuone Co Ltd's revenue is 6%. The projected CAGR for the next 3 years is 6%.

6%
Past Growth
6%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Pulmuone Co Ltd

For the last 8 years the compound annual growth rate for Pulmuone Co Ltd's operating income is 6%. The projected CAGR for the next 2 years is 30%.

6%
Past Growth
30%
Estimated Growth
Estimates Accuracy
-8%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Pulmuone Co Ltd

For the last 8 years the compound annual growth rate for Pulmuone Co Ltd's net income is -9%. The projected CAGR for the next 3 years is 91%.

-9%
Past Growth
91%
Estimated Growth
Estimates Accuracy
-44%
Average Miss
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Pulmuone Co Ltd's stock price target?
Price Target
15 810 KRW

According to Wall Street analysts, the average 1-year price target for Pulmuone Co Ltd is 15 810 KRW with a low forecast of 14 140 KRW and a high forecast of 17 850 KRW.

What is Pulmuone Co Ltd's Revenue forecast?
Projected CAGR
6%

For the last 8 years the compound annual growth rate for Pulmuone Co Ltd's revenue is 6%. The projected CAGR for the next 3 years is 6%.

What is Pulmuone Co Ltd's Operating Income forecast?
Projected CAGR
30%

For the last 8 years the compound annual growth rate for Pulmuone Co Ltd's operating income is 6%. The projected CAGR for the next 2 years is 30%.

What is Pulmuone Co Ltd's Net Income forecast?
Projected CAGR
91%

For the last 8 years the compound annual growth rate for Pulmuone Co Ltd's net income is -9%. The projected CAGR for the next 3 years is 91%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 239,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.